$1.16
1.69% today
Nasdaq, Jul 02, 10:00 pm CET
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Molecular Templates, Inc. Share price

$1.18
-0.17 12.59% 1M
-2.55 68.36% 6M
-2.55 68.36% YTD
-5.84 83.19% 1Y
-116.42 99.00% 3Y
-125.72 99.07% 5Y
-673.67 99.83% 10Y
Nasdaq, Closing price Mon, Jul 01 2024
+0.03 2.61%
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Key metrics

Market capitalization $7.77m
Enterprise Value $12.63m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.40
P/S ratio (TTM) P/S ratio 0.24
P/B ratio (TTM) P/B ratio 1.08
Sales growth (TTM) Sales growth -33.68%
Turnover (TTM) Turnover $31.76m
EBIT (operating result TTM) EBIT $-22.30m
Free cash flow (TTM) Free cash flow $-27.72m
Cash position $6.78m
EPS (TTM) EPS $-4.36
P/E ratio expected negative
P/S ratio expected 0.64
EV/Sales expected 1.04
Short interest 4.21%
Show more

Is Molecular Templates, Inc. a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.

Molecular Templates, Inc. Share analysis

Unlock Scores for Free

Analyst opinions

1 Analyst has issued a forecast Molecular Templates, Inc.:

1x Buy
100%

Analyst opinions

1 Analyst has issued a forecast Molecular Templates, Inc.:

Buy
100%

Financial data from Molecular Templates, Inc.

Assets
Dec '23
17 17
Cash position 12 12
Claims 0.25 0.25
Inventories - -
Other current assets Other current assets Current assets 5 5
19 19
Property, plant and equipment 17 17
Financial assets 1.32 1.32
Intangible assets 0.60 0.60
Other fixed assets Other assets Fixed assets 0.14 0.14
Total assets 35 35
Liabilities
Dec '23
Equity 4.21 4.21
31 31
Current liabilities 17 17
Non-current liabilities 14 14
Total capital 35 35

Figures in millions USD.

Don't miss a thing! We will send you all news about the Molecular Templates, Inc. share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Molecular Templates, Inc. Share News

Neutral
GlobeNewsWire
29 days ago
AUSTIN, Texas, June 03, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage company focused on the discovery and development of targeted biologic therapeutics with unique mechanisms of action (engineered toxin bodies or “ETBs”) for cancer and immune-mediated disease, today provided an update on its clinical-stage programs.
Neutral
GlobeNewsWire
about 2 months ago
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results ...
Neutral
GlobeNewsWire
3 months ago
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action for cancer, today announced that...
More Molecular Templates, Inc. News

Company profile

Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.

Head office United States
CEO Eric Poma
Employees 62
Founded 2000
Website www.mtem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today